Get started
Author

Shelly R. Gunn

Observed names: Gunn, Shelly, S Gunn, S R Gunn, S. Gunn, Shelly Gunn, Shelly R Gunn
OpenAlex ID: A5076703249
The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer
2012 · Toshio Shimizu, Anthony W. Tolcher, et al. · Clinical Cancer Research · 444
Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event
2009 · I-Tien Yeh, Mathew A Martin, et al. · Modern Pathology · 143
PDF
Molecular characterization of a patient with central nervous system dysmyelination and cryptic unbalanced translocation between chromosomes 4q and 18q
2003 · Shelly R. Gunn, Mansoor Mohammed, et al. · American Journal of Medical Genetics Part A · 109
Whole-Genome Scanning by Array Comparative Genomic Hybridization as a Clinical Tool for Risk Assessment in Chronic Lymphocytic Leukemia
2008 · Shelly R. Gunn, Mansoor S. Mohammed, et al. · Journal of Molecular Diagnostics · 80
Molecular and clinical characterization of a recurrent cryptic unbalanced t(4q;18q) resulting in an 18q deletion and 4q duplication
2008 · Craig Horbinski, Erika M. Carter, et al. · American Journal of Medical Genetics Part A · 76
Multiparametric liquid biopsy analysis in metastatic prostate cancer
2019 · Emmanuelle Hodara, Gareth Morrison, et al. · JCI Insight · 63
PDF
Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME gene
2008 · Shelly R. Gunn, Aswani R. Bolla, et al. · Leukemia Research · 61
Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity
2010 · Shelly Gunn, I-Tien Yeh, et al. · BMC Cancer · 57
PDF
Analytical performance evaluation of a commercial next generation sequencing liquid biopsy platform using plasma ctDNA, reference standards, and synthetic serial dilution samples derived from normal plasma
2020 · Suman Verma, Mathew W. Moore, et al. · BMC Cancer · 46
PDF
Atypical 11q deletions identified by array CGH may be missed by FISH panels for prognostic markers in chronic lymphocytic leukemia
2009 · S R Gunn, M K Hibbard, et al. · Leukemia · 29
Clinical Application of Array-Based Comparative Genomic Hybridization for the Identification of Prognostically Important Genetic Alterations in Chronic Lymphocytic Leukemia
2008 · Russell A. Higgins, Shelly R. Gunn, et al. · Molecular Diagnosis & Therapy · 23
Use of DNA Sequencing Analysis To Confirm Fungemia Due to Trichosporon dermatis in a Pediatric Patient
2006 · Shelly R. Gunn, Xavier T. Reveles, et al. · Journal of Clinical Microbiology · 21
A novel familial 11p15.4 microduplication associated with intellectual disability, dysmorphic features, and obesity with involvement of the ZNF214 gene
2011 · Elvera Sofos, Matthew F. Pescosolido, et al. · American Journal of Medical Genetics Part A · 20
Comparative Genomic Hybridization Arrays in Clinical Pathology
2007 · Shelly R. Gunn, Ryan S. Robetorye, et al. · Molecular Diagnosis & Therapy · 20
The genetics of interdigitating dendritic cell sarcoma share some changes with Langerhans cell histiocytosis in select cases
2013 · Dennis P. O'Malley, Lawrence Zuckerberg, et al. · Annals of Diagnostic Pathology · 17
Array-Based Karyotyping in Plasma Cell Neoplasia After Plasma Cell Enrichment Increases Detection of Genomic Aberrations
2012 · Barbara K. Zehentner, Luise Hartmann, et al. · American Journal of Clinical Pathology · 14
Inversion and deletion of 16q22 defined by array CGH, FISH, and RT-PCR in a patient with AML
2011 · Angelika J. Dawson, Shibani Bal, et al. · Cancer Genetics · 12
Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer
2013 · Shelly Gunn, Xavier Reveles, et al. · Journal of Ovarian Research · 11
PDF
The Vanguard Has Arrived in the Clinical Laboratory
2010 · Shelly R. Gunn · Journal of Molecular Diagnostics · 7
The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in first-in-human phase I study: The START Center experience.
2011 · T. Shimizu, A. W. Tolcher, et al. · Journal of Clinical Oncology · 6
Reference Size Matching, Whole-Genome Amplification, and Fluorescent Labeling as a Method for Chromosomal Microarray Analysis of Clinically Actionable Copy Number Alterations in Formalin-Fixed, Paraffin-Embedded Tumor Tissue
2018 · Shelly R. Gunn, Shailin Govender, et al. · Journal of Molecular Diagnostics · 5
Validation of an Array CGH Test for HER2 Status Using Tumor-Targeted DNA Extraction from Formalin Fixed Tissue: Comparison with Fresh Frozen Tissue Results.
2009 · S. Gunn, M. Gorre, et al. · Cancer Research · 5
The role of new genetic technology in investigating autism and developmental delay.
2011 · Natasha Shur, Shelly Gunn, et al. · PubMed · 4
Microdeletion of Chromosome 15q24.3–25.2 and Orofacial Clefting
2010 · Bindya Sing, Dongli Song, et al. · The Cleft Palate-Craniofacial Journal · 4
Multi-parametric liquid biopsy analysis of circulating tumor cells (CTCs), cell-free DNA (cfDNA), and cell-free RNA (cfRNA) in metastatic castrate resistant prostate cancer (mCRPC).
2018 · Emmanuelle Hodara, Daniel Zainfeld, et al. · Journal of Clinical Oncology · 3
Works count: 59
Citation count: 1,295
H-index: 15
I10-index: 18
Year
Topic
Type